FINWIRES · TerminalLIVE
FINWIRES

受美股午後下跌影響,交易所交易基金(ETF)小幅走低。

By

-- 大盤指標 綜合市場交易所交易基金IWM和IVV小幅下跌。活躍交易的景順QQQ信託基金(QQQ)下跌0.1%。 週一午盤交易中,由於結束伊朗戰爭的談判陷入僵局,原油期貨價格上漲,打擊了投資人信心,美國股指下跌。 能源板塊 iShares美國能源ETF(IYE)和道富能源精選產業SPDR基金(XLE)均下跌約0.3%。 科技板塊 道富科技精選產業SPDR基金(XLK)下跌0.3%;iShares美國科技ETF(IYW)上漲0.1%;iShares擴展科技業ETF(IGM)下跌約0.3%。 道富SPDR標普半導體ETF(XSD)下跌3.7%;iShares半導體ETF(SOXX)下跌1.9%。 金融 道富金融精選產業SPDR基金(XLF)上漲0.7%。 Direxion每日3倍做多金融股票基金(FAS)上漲2%,而其對應的做空基金Direxion每日3倍做空金融股票基金(FAZ)下跌2.1%。 大宗商品 原油價格上漲1.9%,美國石油基金(USO)上漲1.9%。天然氣價格上漲2.7%,美國天然氣基金(UNG)上漲3.2%。 紐約商品交易所(Comex)黃金價格下跌1.1%,道富SPDR黃金股票基金(GLD)下跌0.9%。白銀價格下跌1.7%,iShares白銀信託基金(SLV)下跌1.1%。 消費品 道富消費必需品精選產業SPDR基金(XLP)下跌0.7%。 Vanguard必需消費品ETF (VDC)下跌0.7%,iShares道瓊斯美國消費品ETF (IYK)下跌0.5%。 State Street非必需消費品精選產業SPDR基金 (XLY)下跌0.5%。 VanEck零售ETF (RTH)下跌0.4%,State Street標普零售ETF (XRT)下跌0.2%。 醫療保健 State Street醫療保健精選產業SPDR基金 (XLV)小幅下跌,iShares美國醫療保健ETF (IYH)下跌0.1%,Vanguard醫療保健ETF (VHT)小幅下跌。 iShares生物技術ETF (IBB)下跌0.1%。 工業 State Street工業精選產業SPDR基金 (XLI)下跌0.2%。 Vanguard工業指數基金 (VIS)和iShares美國工業指數基金 (IYJ)也出現下跌。 加密貨幣 午盤交易中,比特幣(BTC-USD)下跌2.1%。加密貨幣ETF方面,ProShares比特幣ETF(BITO)下跌1.4%,ProShares以太坊ETF(EETH)下跌1.9%,ProShares比特幣和以太幣市值加權ETF(BETH)下跌1.5%。

Related Articles

Insider Trading

Lifestance Health Group Insider Sold Shares Worth $492,400, According to a Recent SEC Filing

Robert Bessler, Director, on April 23, 2026, sold 69,899 shares in Lifestance Health Group (LFST) for $492,400. Following the Form 4 filing with the SEC, Bessler has control over a total of 1,485,228 common shares of the company, with 57,619 shares held directly and 1,427,609 controlled indirectly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1845257/000119312526182153/xslF345X05/ownership.xml

$LFST
Australia

Celestica Q1 Adjusted Earnings, Revenue Rise; Q2 Guidance Set

Celestica (CLS) reported Q1 adjusted earnings late Monday of $2.16 per diluted share, up from $1.20 a year earlier.Analysts polled by FactSet expected $2.07.Revenue for the three months ended March 31 was $4.05 billion, up from $2.65 billion a year earlier.Analysts surveyed by FactSet expected $4.04 billion.For Q2, the company expects adjusted EPS of $2.14 to $2.34 on revenue of $4.15 billion to $4.45 billion. Analysts expect EPS of $2.13 on revenue of $4.17 billion.The company now expects 2026 adjusted EPS of $10.15 on revenue of $19 billion, revised from $8.75 and $17 billion, respectively, expected earlier. Analysts expect EPS of $8.93 on revenue of $17.34 billion.

$CLS
Research

Research Alert: CFRA Keeps Buy Opinion On Shares Of Ameriprise Financial, Inc.

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We keep our 12-month target price of $550, valuing AMP shares at 12.5x our 2026 adjusted EPS estimate of $43.84 (raised by $1.34) and at 11.7x our 2027 EPS estimate of $46.90 (raised by $0.70). This compares to the three-year average forward multiple of 12x and peer average of 15.5x. AMP posted Q1 2026 adjusted operating EPS of $11.26 vs. $9.50, a 19% rise that topped our $10.12 estimate and $10.21 consensus view. Revenue growth of 11% exceeded our forecast and our 6%-10% growth forecast for 2026, while pretax adjusted operating margins expanded 130 bps to 28% on revenue gains and cost containment efforts. We now see revenue growth of 7% to 12% in 2026 and 2027. AMP also continued its substantial capital return program, returning $936M to shareholders in Q1 (70% of adjusted operating earnings) and $3.4B in 2025 (88% of earnings). Currently trading at 10.9x our 2026 EPS estimate, and with some decent revenue and earnings momentum, we view the shares as undervalued versus peer and historical averages.

$AMP